Work

Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy

Year: 2022
Type: review
Abstract: The incidence and prevalence of diabetes mellitus (DM) are increasing worldwide, and the resulting cardiac complications are the leading cause of death. Among these complications is diabetes-induced cardiomyopathy (DCM), which is the consequence of a pro-inflammatory condition, oxidative stress and fibrosis caused by hyperglycemia. Cardiac remodeling will lead to an imbalance in cell survival and death, which can promote cardiac dysfunction. Since the conventional treatment of DM generally does not address the prevention of cardiac remodeling, it is important to develop new alternatives for the treatment of cardiovascular complications induced by DM. Thus, therapy with mesenchymal stem cells has been shown to be a promising approach for the prevention of DCM because of their anti-apoptotic, anti-fibrotic and anti-inflammatory effects, which could improve cardiac function in patients with DM.
Source: Cells
Language: English
Subfield: Cell Biology
Open Access status: gold
Estimated APC paid: $2,303
OpenAlex ID: W4205435595
FWCI: 0.888
Cites: 139
Cited by: 35
Related to: 10